ResMed SEC filings, summarized
We read every ResMed 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.
Track RMD in your inbox
Add ResMed to your watchlist — free, every morning.
Recent filings
ResMed filed an 8‑K (Item 9.01) attaching a press release dated Jan 29, 2026 reporting results of…
ResMed filed an 8‑K (Item 9.01) attaching a press release dated Jan 29, 2026 reporting results of operations (Exhibit 99.1). Signed by CFO Brett Sandercock.…
ResMed ($RMD) board declared a quarterly cash dividend of $0.60/share.
ResMed ($RMD) board declared a quarterly cash dividend of $0.60/share. Record date Feb 12, 2026; ex-dividend date Feb 11, 2026; payable Mar 19, 2026.…
ResMed ($RMD) furnished a press release (Exhibit 99.1) on Jan 29, 2026 reporting results for the quarter…
ResMed ($RMD) furnished a press release (Exhibit 99.1) on Jan 29, 2026 reporting results for the quarter ended Dec 31, 2025. Investors: see the release for…